Comparative efficacy and safety of oral P2Y12 inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis | Open Heart

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Topic collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Citation Tools

PDF +
Supplementary
Material

Meta-analysis

Original research

Comparative efficacy and safety of oral P2Y₁₂ inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:: Farmakis IT, Zafeiropoulos S, Doundoulakis I, et al

Comparative efficacy and safety of oral P2Y₁₂ inhibitors after non-ST-elevation acute coronary syndromes: a network meta-analysis

Open Heart 2022;9:e001937. doi: 10.1136/openhrt-2021-001937